Stryker Corporation  

(Public, NYSE:SYK)   Watch this stock  
Find more results for SYK
114.44
+1.13 (1.00%)
Real-time:   10:41AM EDT
NYSE real-time data - Disclaimer
Currency in USD
Range 113.24 - 114.62
52 week 86.68 - 123.55
Open 113.67
Vol / Avg. 111,672.00/1.26M
Mkt cap 43.10B
P/E 26.99
Div/yield 0.38/1.33
EPS 4.24
Shares 374.00M
Beta 0.77
Inst. own 79%
Nov 9, 2016
Stryker Corp Analyst Meeting and Product Fair Add to calendar
Oct 27, 2016
Q3 2016 Stryker Corp Earnings Release - 4:00PM EDT - Add to calendar
Sep 8, 2016
Stryker Corp at Wells Fargo Securities Healthcare Conference - 9:55AM EDT - Add to calendar
Jul 21, 2016
Q2 2016 Stryker Corp Earnings Call - Webcast
Jul 21, 2016
Q2 2016 Stryker Corp Earnings Release
Jun 7, 2016
Stryker Corp at Goldman Sachs Global Healthcare Conference
More events from DailyFinance »    

Key stats and ratios

Q2 (Jun '16) 2015
Net profit margin 13.38% 14.47%
Operating margin 17.61% 18.71%
EBITD margin - 26.68%
Return on average assets 7.59% 8.59%
Return on average equity 17.02% 16.82%
Employees 27,000 -
CDP Score - 54 E

Address

2825 Airview Blvd
PORTAGE, MI 49002-1802
United States - Map
+1-269-3892600 (Phone)
+1-269-3851062 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
About Company - Wikipedia

Description

Stryker Corporation (Stryker) is a medical technology company. The Company operates through three segments: Orthopaedics, MedSurg, and Neurotechnology and Spine. The Company's Orthopaedics segment products consist of implants used in hip and knee joint replacements and trauma and surgeries. The Company's MedSurg segment products consist of surgical equipment and surgical navigation systems (Instruments); endoscopic and communications systems (Endoscopy); patient handling and emergency medical equipment (Medical), and reprocessed and remanufactured medical devices (Sustainability), as well as other medical device products used in a range of medical specialties. The Company's Neurotechnology and Spine segment products consist of both neurosurgical and neurovascular devices. The Company's products are sold in approximately 100 countries through the Company-owned sales subsidiaries and branches, as well as third-party dealers and distributors.

Officers and directors

Kevin A. Lobo Chairman of the Board, Chief Executive Officer
Age: 50
Bio & Compensation  - Reuters
Glenn S Boehnlein Chief Financial Officer, Vice President
Bio & Compensation  - Reuters
Lonny J. Carpenter Group President - Global Quality and Operations
Age: 54
Bio & Compensation  - Reuters
David K. Floyd Group President - Orthopaedics
Age: 55
Bio & Compensation  - Reuters
Timothy J. Scannell Group President - MedSurg and Neurotechnology
Age: 51
Bio & Compensation  - Reuters
William E. Berry Jr. Principal Accounting Officer, Vice President, Corporate Controller
Age: 50
Bio & Compensation  - Reuters
Bijoy S.N. Sagar Chief Information Officer, Vice President
Age: 47
Bio & Compensation  - Reuters
M. Kathryn Fink Vice President - Global Human Resources
Age: 46
Bio & Compensation  - Reuters
Katherine A. Owen Vice President - Strategy and Investor Relations
Age: 45
Bio & Compensation  - Reuters
Yin C. Becker Vice President - Communication and Public Affairs
Age: 52
Bio & Compensation  - Reuters